| I\'m on holiday http://www.theinkednaturalist.co.uk/about-me/ authoritative millimetre order bupropion uk counsel variations Drugmaker Retrophin Inc said it offered to buy therest of Transcept Pharmaceuticals shares it does not already ownfor $4 per share, valuing Transcept at about $75 million.Retrophin\'s offer represents an 11 percent premium toTranscept\'s closing share price of $3.59 on the Nasdaq onWednesday.
|
|